Glycoprotein IIb/IIa inhibition with abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency.

被引：0
|
作者：
Jeremias, A [1 ]
Bhatt, DL [1 ]
Chew, DP [1 ]
Ziada, KM [1 ]
Albirini, A [1 ]
Brener, SJ [1 ]
Lincoff, AM [1 ]
Ellis, SG [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 5A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT250
引用
收藏
页码：97G / 98G
页数：2
相关论文
共 50 条
  • [1] Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency
    Jeremias, A
    Bhatt, DL
    Chew, DP
    Ziada, KM
    Albirini, A
    Brener, SJ
    Lincoff, M
    Topol, EJ
    Ellis, SG
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (10): : 1209 - +
  • [2] Glycoprotein IIb/IIIa Inhibitors in Patients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention
    Anderson, Joe R.
    Riding, Dan
    CARDIOLOGY IN REVIEW, 2008, 16 (04) : 213 - 218
  • [3] Effects of platelet glycoprotein IIb IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention
    Dangas, G
    Marmur, JD
    King, TE
    De Leon, J
    Sharma, SK
    Vidhun, R
    Feldman, D
    Stoynov, MY
    Badimon, JJ
    Ambrose, JA
    AMERICAN HEART JOURNAL, 1999, 138 (01) : 49 - 54
  • [4] Safety and efficacy of glycoprotein IIb/IIIa receptor blockers in patients with chronic renal insufficiency undergoing contemporary percutaneous coronary intervention
    Moscucci, M
    Smith, DE
    Riba, A
    Goswami, R
    DeFranco, A
    Khanal, S
    O'Donnell, M
    Share, D
    Eagle, KA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 415A - 415A
  • [5] Glycoprotein IIb/IIIa receptor inhibition with abciximab during percutaneous coronary interventions increases the risk of bleeding in patients with impaired renal function
    Pinkau, Tobias
    Ndrepepa, Gjin
    Kastrati, Adnan
    Mann, Johannes F. E.
    Schulz, Stefanie
    Mehilli, Julinda
    Schoeming, Albert
    CARDIOLOGY, 2008, 111 (04) : 247 - 253
  • [6] The safety of abciximab before percutaneous coronary revascularization in patients with chronic renal insufficiency
    Best, PJM
    Lennon, R
    Ting, HH
    Bell, MR
    Rihal, CS
    Holmes, DR
    Berger, PB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 4A - 4A
  • [7] Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management
    Dippel, EJ
    Kereiakes, DJ
    Tramuta, DA
    Broderick, TM
    Shimshak, TM
    Roth, EM
    Hattemer, CR
    Runyon, JP
    Whang, DD
    Schneider, JF
    Abbottsmith, CW
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2001, 52 (03) : 279 - 286
  • [8] Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
    Best, PJM
    Lennon, R
    Gersh, BJ
    Ting, HH
    Rihal, CS
    Bell, MR
    Herzog, CA
    Holmes, DR
    Berger, PB
    AMERICAN HEART JOURNAL, 2003, 146 (02) : 345 - 350
  • [9] Glycoprotein IIb/III Inhibition During Acute Percutaneous Coronary Intervention: Tool or Talisman?
    El-Jack, Seif
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2013, 26 (04) : 340 - 342
  • [10] Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients with Chronic Renal Insufficiency
    Rha, Seung-Woon
    Choi, Byoung Geol
    Choi, Se Yeon
    Elnagar, Amro
    Im, Sung Il
    Kim, Sun Won
    Na, Jin Oh
    Han, Seong Woo
    Choi, Cheol Ung
    Lim, Hong Euy
    Kim, Jin Won
    Kim, Eung Ju
    Seo, Hong Seog
    Park, Chang Gyu
    Oh, Dong Joo
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 96S - 96S
12345